CONCENTRATION-CONTROLLED OR EFFECT-CONTROLLED CLINICAL-TRIALS WITH SPARSE DATA

被引：45

作者：

LEVY, G

EBLING, WF

FORREST, A

机构：

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1994年 / 56卷 / 01期

关键词：

D O I：

10.1038/clpt.1994.93

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1 / 8

页数：8

共 20 条

[11]

LEVY G, 1985, VARIABILITY DRUG THE, P125

[12] PHARMACOKINETIC-PHARMACODYNAMIC MODELING OF THE CENTRAL-NERVOUS-SYSTEM EFFECTS OF MIDAZOLAM AND ITS MAIN METABOLITE ALPHA-HYDROXYMIDAZOLAM IN HEALTHY-VOLUNTEERS [J].

MANDEMA, JW ;

TUK, B ;

VANSTEVENINCK, AL ;

BREIMER, DD ;

COHEN, AF ;

DANHOF, M .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (06) :715-728

[13] TINNITUS AS AN INDICATION OF THERAPEUTIC SERUM SALICYLATE LEVELS [J].

MONGAN, E ;

KELLY, P ;

NIES, K ;

PORTER, WW ;

PAULUS, HE .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1973, 226 (02) :142-145

[14] PHARMACODYNAMIC VARIABILITY OF FLECAINIDE ASSESSED BY QRS CHANGES [J].

PADRINI, R ;

PIOVAN, D ;

BUSA, M ;

ALBUNNI, M ;

MAIOLINO, P ;

FERRARI, M .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (01) :59-64

[15] CONCENTRATION-CONTROLLED VERSUS CONCENTRATION-DEFINED CLINICAL-TRIALS - REPLY [J].

PECK, CC .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (03) :385-387

[16] LABETALOL IN HYPERTENSION DURING THE 3RD TRIMESTER OF PREGNANCY - ITS ANTIHYPERTENSIVE EFFECT AND PHARMACOKINETIC-DYNAMIC ANALYSIS [J].

SAOTOME, T ;

MINOURA, S ;

TERASHI, K ;

SATO, T ;

ECHIZEN, H ;

ISHIZAKI, T .

JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 33 (10) :979-988

[17]

SHEINER LB, 1979, CLIN PHARMACOL THER, V25, P358

[18]

VOLAVKA J, 1992, ARCH GEN PSYCHIAT, V49, P354

[19] 2-COMPARTMENT BASOPHIL CELL TRAFFICKING MODEL FOR METHYLPREDNISOLONE PHARMACODYNAMICS [J].

WALD, JA ;

SALAZAR, DE ;

CHENG, H ;

JUSKO, WJ .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1991, 19 (05) :521-536

[20] EVALUATION OF DOSE-RELATED PHARMACOKINETICS AND PHARMACODYNAMICS OF PREDNISOLONE IN MAN [J].

WALD, JA ;

LAW, RM ;

LUDWIG, EA ;

SLOAN, RR ;

MIDDLETON, E ;

JUSKO, WJ .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1992, 20 (06) :567-589

← 1 2 →